LIPELLA PHARMACEUTICALS INC. · CIK 1347242
LIPELLA PHARMACEUTICALS INC.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filings
2
Original notices
2
Amendments
0
Activity
Jan 7, 2025
through Apr 1, 2025
through Apr 1, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Jan 7, 2025 · D | Apr 1, 2025 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $6,000,000 | $9,000 | $-5,991,000 |
| Reported amount sold | $2,597,500 | $9,000 | $-2,588,500 |
| Reported investor count | — | — | — |
| Reported minimum investment | $50,000 | $0 | $-50,000 |
Earlier SEC source: 0001753926-25-000060 · Later SEC source: 0001753926-25-000541
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $9,000
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $9,000
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Form D filings (2)
-
0001753926-25-000541D · Apr 1, 2025 · PharmaceuticalsOffering: $9,000Sold: $9,000
Compared with 0001753926-25-000060:
- Reported offering amount: $6,000,000 → $9,000
- Reported amount sold: $2,597,500 → $9,000
- Reported minimum investment: $50,000 → $0
-
0001753926-25-000060D · Jan 7, 2025 · PharmaceuticalsOffering: $6,000,000Sold: $2,597,500